2 recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 2 |
Follow Concurrent chemoradiation: new trials by email Literature Review of Concurrent chemoradiation trials Research Report on Concurrent chemoradiation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Thermotherapy for Head and Neck Cancer Patients Thermotherapy, Radiotherapy, Concurrent chemoradiation - Head and Neck Cancer, Oropharyngeal Carcinoma | Phase 1 | Recruiting | Erasmus Medical Center | 30 | 2026-09-01 | 2026-09-02 |
| Neoadjuvant Immunotherapy Combined With Chemotherapy Sequenced With Endoscopic Resection for Esophageal Cancer (Endosurgery-02) Tislelizumab, Carboplatin, Nab-paclitaxel - Esophageal Squamous Cell Carcinoma (ESCC) | Phase 1 | Recruiting | Shanghai Zhongshan Hospital | 60 | 2025-07-15 | 2026-01-05 |
Esophageal Squamous Cell Carcinoma (1) · Head and Neck Neoplasms (1) · Hyperthermia (1) · Hypopharyngeal Neoplasms (1) · Laryngeal Neoplasms (1) · Mouth Neoplasms (1) · Oropharyngeal Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
Erasmus Medical Center (1) · Shanghai Zhongshan Hospital (1)
China (1) · Netherlands (1)
PMID 12049861, PMID 26254683, PMID 26808342, PMID 29409469, PMID 29441562, PMID 29861116, PMID 31319389, PMID 32143580, PMID 33065643, PMID 34137505, PMID 34454674, PMID 35671803, PMID 36158679, PMID 36322089, PMID 37433041